HA
Haemonetics Corporation (HAZ)
XSTU
91.00
-1.00 (-1.09%)
Real-time Data
06:00 AM
Day's Range
91.0092.50
52 wk Range
41.0096.00
Financial Statements - HAZ - Haemonetics Corporation
Revenue
1.33B▼ 2.0%
Net Income
97.30M▼ 42.0%Net Margin 7.3%
EBITDA
353.11M▲ 11.5%
Free Cash Flow
260.44M▲ 82.8%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Sales | 1.33B | 1.36B | 1.30B |
| Cost of Goods | 546.44M | 611.86M | 617.50M |
| Gross Profit | 787.58M | 748.95M | 691.54M |
 Operating Expense | - | - | - |
| Operating Income | 241.40M | 201.18M | 173.30M |
| Non-Operating Interest | - | - | - |
| Other Income Expense | -84.66M | 20.63M | -8.41M |
| Pre Tax Income | 128.03M | 212.07M | 151.86M |
| Income Tax | 30.72M | 44.39M | 34.30M |
| Net Income | 97.30M | 167.67M | 117.55M |
| EPS Basic | 2.062528 | 3.331591 | 2.32 |
| EPS Diluted | 2.05 | 3.31 | 2.29 |
| Basic Shares Outstanding | 47.17M | 50.33M | 56.97M |
| Diluted Shares Outstanding | 47.17M | 50.33M | 56.97M |
| Ebit | 156.73M | 221.81M | 164.88M |
| Ebitda | 353.11M | 316.77M | 270.51M |
| Net Income Continuous Operations | 97.30M | 167.67M | 117.55M |
| Minority Interests | - | - | - |
| Preferred Stock Dividends | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
